| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 3996790 | Practical Radiation Oncology | 2013 | 6 Pages |
Abstract
Employing SBRT for stage I medically inoperable SCLC is rational, with excellent local control and encouraging disease-specific survival. The absence of regional nodal failure supports positron emission tomography for mediastinal staging. Platinum-based CHT may be feasible in vulnerable populations.
Related Topics
Health Sciences
Medicine and Dentistry
Oncology
Authors
Gregory M.M. MD, CM, Kevin L. MD, Neil M. MD, Nathan A. MD, PhD, Marc MD, Chandana A. MS, Toufik PhD,